跳至主要内容
临床试验/NCT03442582
NCT03442582已完成不适用

A Prospective Observational Safety Study on Pregnancy Outcomes in Women Immunized With Afluria, a Seasonal Influenza Vaccine, During Pregnancy

Seqirus1 个研究点 分布在 1 个国家目标入组 490 人开始时间: 2017年9月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
490
试验地点
1
主要终点
Safety Objective: Number of cases of events of preterm birth among women immunized as part of routine care with Afluria, a seasonal influenza vaccine, during pregnancy.

研究概览

简要总结

The study is a population based prospective cohort study designed to collect data on pregnancy outcomes and events of interest among women immunized with Afluria during pregnancy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
Female
接受健康志愿者

入选标准

  • Enrollment and data collection will be coordinated through a coordination center (CC). The minimum eligibility criteria required for enrollment are as follows:
  • Sufficient information to confirm that the exposure of interest occurred during pregnancy and at which date.
  • Sufficient information to determine whether it concerns a prospectively enrolled subject, since retrospective cases are ineligible for enrollment.
  • Reporter (e.g. HCP) contact information to allow for follow-up

排除标准

  • 未提供

结局指标

主要结局

Safety Objective: Number of cases of events of preterm birth among women immunized as part of routine care with Afluria, a seasonal influenza vaccine, during pregnancy.

时间窗: From time of enrollment during pregnancy to time of delivery or pregnancy termination; a follow-up period of up to 40 weeks

Safety Objective: Number of cases of events of low birth weight among women immunized as part of routine care with Afluria, a seasonal influenza vaccine, during pregnancy.

时间窗: From time of enrollment during pregnancy to time of delivery or pregnancy termination; a follow-up period of up to 40 weeks

Safety Objective: Number of cases for pregnancy outcomes among women immunized as part of routine care with Afluria, a seasonal influenza vaccine, during pregnancy.

时间窗: From time of enrollment during pregnancy to time of delivery or pregnancy termination; a follow-up period of up to 40 weeks

Pregnancy outcomes will be reported as one of the following: live birth, stillbirth, spontaneous abortion and elective termination

Safety Objective: Number of cases with events of major congenital malformations among women immunized as part of routine care with Afluria, a seasonal influenza vaccine, during pregnancy.

时间窗: From time of enrollment during pregnancy to time of delivery or pregnancy termination; a follow-up period of up to 40 weeks

次要结局

未报告次要终点

研究者

发起方
Seqirus
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Afluria Pregnancy Registry | 临床试验